{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T01:34:13Z","timestamp":1755221653704,"version":"3.43.0"},"reference-count":0,"publisher":"Salvia Medical Sciences Ltd","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Galen Med J"],"abstract":"<jats:p>Background: C-peptide, a byproduct of insulin production, plays significant physiological roles, including stabilizing blood glucose levels and protecting tissues. Its potential therapeutic role in Type 1 diabetes mellitus (T1DM) management remains underexplored, particularly in preserving \u03b2-cell function and improving glycemic control. Materials and Methods: This cross-sectional study included 69 pediatric patients with T1DM at Bo Ali Diabetes Clinic, Shiraz, Iran, from December 2022 to April 2023. Patients with a disease duration less than 2 years or metabolic comorbidities were excluded. Anthropometric measurements, HbA1c, and serum C-peptide levels were collected after three months of dietary counseling and insulin adjustment. Data were analyzed using Spearman\u2019s correlation and linear regression. Results: The study population consisted of 69 children (mean age: 11.92 \u00b1 3.65 years; mean disease duration: 63.13 \u00b1 33.16 months). Serum C-peptide levels (mean: 87.02 \u00b1 73.89 pmol\/L) were inversely correlated with disease duration (\u03c1=-0.433, P&lt;0.001) and HbA1c (\u03c1=-0.404, P=0.001). Regression analysis confirmed that both HbA1c and disease duration were significant predictors of C-peptide levels (P&lt;0.05). However, no significant associations were observed between C-peptide and age, weight, height, or BMI. Conclusion: Reduced C-peptide levels are correlated with poorer glycemic control (greater HbA1c) and longer disease duration in children with T1DM. These findings highlight the clinical relevance of C-peptide supplementation as a potential therapeutic strategy to preserve \u03b2-cell function and improve long-term outcomes in T1DM management. Longitudinal studies are warranted to further evaluate its efficacy.<\/jats:p>","DOI":"10.31661\/gmj.v14i.3787","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T06:26:18Z","timestamp":1754720778000},"page":"e3787","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating C-peptide Levels in Children with Type 1 Diabetes and Its Association with Anthropometric and Clinical Variables"],"prefix":"10.31661","volume":"14","author":[{"given":"Raha","family":"Sahraian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anis","family":"Amirhakimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parnia","family":"Kamyab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16705","published-online":{"date-parts":[[2025,8,8]]},"container-title":["Galen Medical Journal"],"original-title":[],"link":[{"URL":"https:\/\/journals.salviapub.com\/index.php\/gmj\/article\/download\/3787\/3258","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.salviapub.com\/index.php\/gmj\/article\/download\/3787\/3259","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.salviapub.com\/index.php\/gmj\/article\/download\/3787\/3258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T06:26:19Z","timestamp":1754720779000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.salviapub.com\/index.php\/gmj\/article\/view\/3787"}},"subtitle":["C-peptide Levels and Clinical Variables in Pediatric T1DM"],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31661\/gmj.v14i.3787","relation":{},"ISSN":["2322-2379","2588-2767"],"issn-type":[{"value":"2322-2379","type":"electronic"},{"value":"2588-2767","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,8]]}}}